Market Cap : 2.88 B | Enterprise Value : 2.44 B | PE Ratio : 28.89 | PB Ratio : 5.94 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was USD2.1 Mil. Corcept Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was USD0.5 Mil. Corcept Therapeutics's Total Stockholders Equity for the quarter that ended in Dec. 2020 was USD523.3 Mil. Corcept Therapeutics's debt to equity for the quarter that ended in Dec. 2020 was 0.00.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
During the past 13 years, the highest Debt-to-Equity Ratio of Corcept Therapeutics was 0.81. The lowest was -2.78. And the median was 0.01.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Corcept Therapeutics's Debt-to-Equity falls into.
Debt to Equity measures the financial leverage a company has.
Corcept Therapeutics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2020 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (2.05 | + | 0.501) | / | 523.338 | |
= | 0.00 |
Corcept Therapeutics's Debt to Equity Ratio for the quarter that ended in Dec. 2020 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (2.05 | + | 0.501) | / | 523.338 | |
= | 0.00 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
No Headline